Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sébastien Taix

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annales De Pathologie|October 11, 2020
[Point of view: A lesson from lockdown, histopathology through videoconferencing]Clémence Delteil, Aurélie Haffner, Radia Fritih, et al.
Frontiers in Immunology|May 5, 2018
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 InhibitorsMarjorie Faure, Philippe Rochigneux, Daniel Olive, et al.
BJU International|September 13, 2016
Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real-life experienceNicolas Branger, Thomas Maubon, Miriam Traumann, et al.
Breast (Edinburgh, Scotland)|May 24, 2016
Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosisRenaud Sabatier, Laura Sabiani, Christophe Zemmour, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annales De Pathologie|October 11, 2020
[Point of view: A lesson from lockdown, histopathology through videoconferencing]Clémence Delteil, Aurélie Haffner, Radia Fritih, et al.
Frontiers in Immunology|May 5, 2018
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 InhibitorsMarjorie Faure, Philippe Rochigneux, Daniel Olive, et al.
BJU International|September 13, 2016
Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real-life experienceNicolas Branger, Thomas Maubon, Miriam Traumann, et al.
Breast (Edinburgh, Scotland)|May 24, 2016
Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosisRenaud Sabatier, Laura Sabiani, Christophe Zemmour, et al.
Pageof 1